What are the indications and contraindications for transjugular intrahepatic portosystemic shunt (TIPS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Indications and Contraindications for TIPS

Primary Indications

TIPS is strongly recommended for three main indications in cirrhotic patients: refractory ascites, acute variceal hemorrhage (particularly as preemptive TIPS in high-risk patients), and hepatic hydrothorax requiring recurrent thoracentesis 1, 2.

Variceal Bleeding

  • Preemptive TIPS should be placed in patients with acute variceal bleeding who are at high risk for treatment failure (typically Child-Pugh B with active bleeding or Child-Pugh C <14 points) after successful initial endoscopic control 2, 3
  • This approach achieves hemorrhage control in 90-100% of cases and significantly improves survival compared to standard therapy 3, 4
  • Despite strong evidence, less than 20% of eligible patients currently receive preemptive TIPS 3

Refractory Ascites

  • TIPS is superior to serial large volume paracentesis (LVP) for both ascites control and transplant-free survival in carefully selected patients 2
  • Consider TIPS even in patients not meeting strict refractory criteria if they require ≥3 large volume paracenteses yearly despite optimal medical therapy 2
  • Use ePTFE-covered controlled expansion stents with staged dilation: start at 8mm, then progressively dilate to 9mm and 10mm at 6-week intervals based on clinical response 2
  • Expected timeline for effectiveness: reassess every 6 weeks while maintaining diuretics as tolerated 2

Hepatic Hydrothorax

  • TIPS should be considered for patients requiring recurrent thoracentesis 2
  • Patient selection criteria are similar to those for refractory ascites 2

Absolute Contraindications

The following are absolute contraindications to TIPS placement 3:

  • Severe uncontrolled hepatic encephalopathy
  • Systemic infection or sepsis
  • Congestive heart failure
  • Severe pulmonary arterial hypertension
  • Biliary obstruction

Relative Contraindications and Risk Factors

Liver Dysfunction Thresholds

While elevated bilirubin, elevated MELD score, and Child-Pugh class C cirrhosis are associated with increased post-TIPS complications and mortality, there is insufficient evidence to recommend absolute cutoffs 2. However, most centers consider bilirubin >5 mg/dL as a relative contraindication 5.

Age Considerations

Advanced age is significantly associated with severe hepatic encephalopathy and death post-TIPS, but no specific age cutoff should be considered an absolute contraindication 2. Clinical judgment based on overall functional status is more important than chronological age alone.

Cardiac and Renal Function

Assessment of cardiac and renal function prior to TIPS is essential to improve patient prognosis 4. Right heart catheterization should be considered in patients with suspected cardiac dysfunction.

Pre-Procedure Requirements

A hepatogastroenterologist must be involved in the initial decision for elective TIPS, with subsequent consultation by a competent proceduralist 1. If center expertise is unavailable, referral to an expert center is mandatory 1.

Additional specialty consultations (transplant surgery, cardiology, nephrology, neurology) should be considered case-by-case 1.

Common Pitfalls to Avoid

  • Underutilization of preemptive TIPS: Despite Level 1 evidence, most eligible high-risk variceal bleeding patients are not offered this life-saving intervention 3
  • Inappropriate patient selection: Failure to assess cardiac function, hepatic encephalopathy risk, and liver dysfunction severity leads to poor outcomes
  • Inadequate staged approach for ascites: Starting with oversized stents increases complications; always begin at 8mm and titrate upward 2
  • Ignoring multidisciplinary evaluation: TIPS decisions require input from hepatology and interventional radiology at minimum 1

Special Populations

Post-liver transplant patients with refractory ascites: There is insufficient evidence to support TIPS or recommend it over alternative therapies in this population 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.